<DOC>
	<DOCNO>NCT01673542</DOCNO>
	<brief_summary>Prospective Study , monocentric , control , randomize study . Evaluating effectiveness dermal analgesia provide application Lidocaine Prilocaine Cream 5 % puncture site axillary blocks.Our study include 70 patient . Number subject require 50 % difference standard deviation control group , significance level 5 % 80 % power , take 23 people per group . Objective power 90 % obtain 35 patient per group . The expected benefit reduction pain skin puncture realization BAX . Improving professional practice quality care</brief_summary>
	<brief_title>Evaluating Effectiveness Dermal Analgesia Provided Application Lidocaine Prilocaine Cream 5 % Puncture Site Axillary Blocks</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<criteria>Age ≥ 18 year Hospitalized upper extremity surgery schedule Having axillary block anesthesia . Free subject , without subordination guardianship Patients undergoing social security system benefit third party Informed consent sign patient clear honest information study Age &lt; 18 year Hypersensitivity lidocaine , prilocaine , one excipients , castor oil derivative Hypersensitivity local anesthetic amide Congenital Methemoglobinemia Porphyrias Glucose6phosphate dehydrogenase Hypersensitivity component Dexeryl ® Disorders atrioventricular conduction require permanent pacing yet realize . Epilepsy uncontrolled treatment Patients anticoagulant Skin infection puncture site Patients psychiatric disorder dementia Consindication infusion Isofundine ® : Severe congestive heart failure anuria oligoanuria Fluid retention hyperkalemia hypercalcemia Metabolic alkalosis Patients receive social security system qualify third party People receive protection ie minor , person deprive liberty judicial administrative decision , guest stay hospital office , adult legal protection , Pregnant nursing woman , woman childbearing age effective contraception ( hormonal / mechanical : oral , injectable , transdermal , implantable , intrauterine device , surgical : tubal ligation , hysterectomy , oophorectomy total )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>